This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
Genomic Biomarker Testing
PEACE-3 Trial
PROfound Trial
PSMAfore Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
BOND-003 Cohort P
CORE-001 Study
CORE-008
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Daniel D. Joyce, MD, MS
Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Ashish Kamat, MD
Muscle-Invasive Bladder Cancer
Advanced & Metastatic Bladder Cancer (mUC)
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Testicular, Penile & Rare GU Malignances
Testicular Cancer
Functional Urology
Functional Urology
Alan J. Wein, MD, PhD (hon.)
Urologic Catheters - CAUTI Challenges
Videos
Exclusives
Conferences
Disparities: Social Determinants of Health
Exclusive Collaborations
Health Policy in Urological Diseases
Independent Medical Education
Journal Clubs
Practice Guidelines Reviews
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Functional Urology
Men's Health
Pelvic Health
Actionable Clinical Data
Bladder Cancer
NMIBC with CIS: Evidence, Practice & Emerging Research
Risk-Stratified NMIBC Management
Trials in Progress
Prostate Cancer
Localized Prostate Cancer
CLARIFY
ESCAPE
FORT
NRG-GU 0101
RTIRE
High Risk BCR HSPC
ARASTEP
Oligometastatic Prostate Cancer
METANOVA
mHSPC
ARASEC
ASPIRE
MEVPRO-3
mCRPC
ECLIPSE
LEGION-100
MEVPRO-1 & 2
PROMISE
SECuRE
Bladder Cancer
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2026
ASCO 2026
AUA 2026
APCCC 2026
PSMA and Beyond 2026
All Conferences
View All
PCF
UroToday Home
Newsletter Archive
Men's Health Weekly
Uroalerts Men's Health Weekly
March 10, 2026
Videos
Peer-to-Peer Clinical Conversations
Bladder-Centric Focus in BPH: Early Triage and a Five-Stage Model - Wayne Kuang
Wayne Kuang discusses his ManVsProstate initiative with Alan Wein, emphasizing bladder health preservation in BPH.
View
Overview of Surgical Treatments for Male Stress Urinary Incontinence - Craig Comiter
Craig Comiter
Alan Wein interviews Craig Comiter about post-prostatectomy incontinence management.
View
Beyond the Abstracts
CHD1 Loss Reprograms SREBP2-Driven Cholesterol Synthesis to Fuel Androgen-Responsive Growth and Castration Resistance in SPOP-Mutated Prostate Tumors - Beyond the Abstract
Robotic Retroperitoneal Lymph-Node Dissection for Testicular Cancer: Initial Experience - Beyond the Abstract
Articles
Editor Selected Abstracts and Commentaries
Androgen Deficiency
The Mortality Gap Between Men and Women
Male Infertility
A novel CFAP57 nonsense mutation causes asthenozoospermia in a consanguineous Emirati family.
Sperm motility in mice with oligo-astheno-teratozoospermia restored by in vivo injection and electroporation of naked mRNA.
The WHO 2025 Guideline for the Prevention, Diagnosis and Treatment of Infertility: A Comprehensive Review with Focus on Male Reproductive Health.
Assessing the epigenetic consequences of ART in male infertility: what risks to embryo and offspring health?
Peyronie's Disease
Guideline of guidelines: Peyronie's disease.
Extracorporeal shock wave therapy (ESWT) in the treatment of Peyronie's disease: our initial experience.
Prostatitis
Outcomes of six dogs with prostate carcinoma and bacterial prostatitis treated with prostate artery embolization.
Erectile Dysfunction
Current treatment for erectile dysfunction: an umbrella review of systematic reviews and meta-analyses.
Defining clinically relevant responses in erectile function: an SMSNA position statement.
A systematic review of regulatory approved drugs and pharmacological interventions for erectile dysfunction.
BPH - Benign Prostatic Enlargement
Perioperative outcomes of ongoing antithrombotic therapy during endoscopic surgery for benign prostatic hyperplasia: a systematic review and meta-analysis of observational studies.
Disease Progression and Outcomes in Patients With Benign Prostatic Hyperplasia: Protocol for a Multicenter Retrospective Cohort Study.
Frailty and frailty progression in relation to the risk of benign prostatic hyperplasia/lower urinary tract symptoms among Chinese middle-aged and older men: a prospective cohort study.
Failed Trial Without Catheter Post Rezūm in Non-Catheter Dependent Patients: Risk Factors From the Canadian Rezūm Registry.
Personalizing BPH Management: Bladder Stone Removal Alone vs. With Concomitant Laser Enucleation-A Multicenter Perspective With Patient Reported Outcomes and Decisional Regret Analysis.
Penile & Urethral Cancers
Penile metastasis from prostate cancer with CDK12 mutation: A case report and literature review.
Low yield of pathological lymph node metastasis among patients with invasive penile squamous cell carcinoma in the context of high HIV burden: evidence from a prospective cohort study in Zambia.
Testicular Cancer
Impact of Chemotherapy on Sperm Functional Characteristics in Patients With Testicular Germ Cell Tumours.
Genomic landscape of pediatric germ cell tumors reveals oncogenic mutations and copy number alterations.
Risk of childhood and adolescent, and young adult cancer in offspring of men with testicular cancer: A Danish nationwide study.
Prostate Cancer
Risks of thrombosis and hemorrhage in concurrent use of anticoagulants and potential interacting prostate cancer agents.
Risk of fracture following androgen receptor pathway inhibitors in men with advanced prostate cancer.
A Pilot Feasibility Study of a Group-Based Remote-Delivered Dyadic Exercise Intervention in Hispanic Men With Prostate Cancer and Their Caregivers.
Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression.
MR-Linac-Based SBRT for Prostate Cancer: Dosimetric Benefits for Urethral Sparing Compared to VMAT and Tomotherapy.
Clinical value of per-treatment whole-body single-time-point automated dosimetry for [177Lu]Lu-PSMA-617 therapy in metastatic castration-resistant prostate cancer.
Natural history of untreated prostate cancer: a comprehensive review of long-term progression patterns and survival outcomes.
Predictors of Early and Late Oncologic Failure After Primary Prostate Cryoablation for Localized Prostate Cancer.
A phase I study of hydroxychloroquine and suba-itraconazole in men with biochemical relapse of prostate cancer (HITMAN-PC): dose escalation results.
Prostate-Specific Membrane Antigen Radioligand Therapy in Patients with Aggressive-Variant Prostate Cancer.
Clinical Utility of Transcriptomic Signatures to Identify Androgen Receptor and Neuroendocrine Signaling in Prostate Cancer.
Molecular Landscape of Prostate Cancers with Clival Metastases.
Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection
Androgen deprivation, androgen receptor-targeted vaccination, and nivolumab in patients with high-risk localized prostate cancer.
Safe to Spare? Predictors of Oncological Safety for Nerve-Sparing Technique during Robot-Assisted Radical Prostatectomy in High-Risk Prostate Cancer. Insight from a High Volume Center with Centralized mpMRI Review.
Treatment of metastatic hormone-sensitive prostate cancer.
Phase 1 Trial of P-PSMA-101 CAR-T Cells in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC).
PSMA PET/CT in diagnosing and staging high grade prostate cancer: accuracy and cost-effectiveness.
Budget impact model of nadofaragene firadenovec for the treatment of high-risk non-muscle-invasive bladder cancer that is unresponsive to Bacillus Calmette-Guérin immunotherapy.
Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups.
Impact of a Precision Medicine Navigator on Genomic Test Utilization in Black Patients With Prostate Cancer.
Neoadjuvant Fc-enhanced anti-CTLA-4 targets Tregs to augment androgen deprivation in high-risk prostate cancer: A randomized phase I trial.
MRI for Active Surveillance in Prostate Cancer: How I Do It.
Impact of smoking on health-related quality-of-life outcomes in prostate cancer survivors.
Assessing PSMA Receptor Availability Using 68Ga-PSMA-11 PET/CT Following 177Lu-PSMA-617 Therapy Administration.
Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohort.
Real-world functional and oncologic outcomes of prostate gland ablation vs. standard of care therapies for localized prostate: A retrospective cohort study using the TriNetX database.
Diagnostic value of prostate magnetic resonance imaging in men with prostate-specific antigen levels ≥ 15 ng/mL for biopsy decision-making.
Discrepancies Between Global Consensus and Local Implementation in the Management of Advanced Prostate Cancer.
Prevention of lymphoceles using peritoneal flaps during robotic-assisted radical prostatectomy with pelvic lymph node dissection: A systematic review and meta-analysis.
68Ga-PSMA-11 PET/CT for Initial Staging of Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Predicts Overall Survival: An IAEA Multicenter Study - Beyond the Abstract
Impact of Surgical Waiting List on Oncological Outcomes of Radical Prostatectomy in Patients with Intermediate- and High-Risk Prostate Cancer - Beyond the Abstract
Local Prostate Cancer Recurrence after Radiotherapy or Brachytherapy. What Now? Retrospective Analysis of Salvage Prostatectomy and Salvage Cryoablation - Beyond the Abstract
Robotic-Assisted Radical Prostatectomy in Patients 80+ Years: A Multi-Centre Experience - Beyond the Abstract
CONNECT WITH US
Questions or Comments? Email us at
editors@urotoday.com
Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523
You are receiving this email because you have chosen to receive emails from UroToday.
Add us to your address book
View this email as a web page
Forward to a colleague
Manage your subscriptions
Unsubscribe
Copyright ©2026 Digital Science Press, LLC
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free